Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03819660Phase 2Terminated
Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Spinal Muscular Atrophy Type 3
PrincipalinvestigatorStart date: 2019-03-07
NCT03781479Phase 2Completed
Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients
Muscular Atrophy, Spinal
PrincipalinvestigatorStart date: 2019-01-21

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Carlo Besta Institute, Milan, Italy

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jacqueline Montes, Pt, EdD

Columbia University

Moderately Similar
4 trials

Shared therapeutic areas:

Muscular Atrophy, SpinalSpinal Muscular Atrophy Type 3
Similarity Score30%

Leonard FEASSON, MD PhD

Centre Hospitalier Universitaire de Saint Etienne

Related
3 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Richard Finkel, MD

St. Jude Children's Research Hospital

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Miguel Angel Fernández García Miguel Angel Fernández García

Hospital Universitario La Paz

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Walter Truong, MD

Gillette Children's Specialty Healthcare

Related
3 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Feyza Sever

Ankara City Hospital Bilkent

Related
5 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Tamis W Pin, PhD

The Hong Kong Polytechnic University

Related
4 trials

Shared therapeutic areas:

Spinal Muscular Atrophy Type 3
Similarity Score15%

Sahar MA Hassanein, MD, PhD

Pediatric Department, Children's Hospital, Faculty of Medicine, Ain Shams University

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Woo Hyung Lee, MD, PhD

Seoul National University Hospital

Related
2 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Mónica Povedano Panadés

Hospital Universitari de Bellvitge

Related
1 trials

Shared therapeutic areas:

Muscular Atrophy, Spinal
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03819660Phase 2PrincipalInvestigator

Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3

Spinal Muscular Atrophy Type 3
Terminated
NCT03781479Phase 2PrincipalInvestigator

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

Muscular Atrophy, Spinal
Completed

All 2 trials loaded